Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Corbus Pharmaceuticals Holdings, Inc. - Common Stock (NQ:CRBP)

8.270 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Corbus Pharmaceuticals Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Cannabis Stock Movers For April 17, 2025
Via Benzinga
Topics Cannabis
Cannabis Stock Gainers And Losers From April 16, 2025
Via Benzinga
Topics Cannabis
Bearish Tuesday For Marijuana Stocks - Rocky Mountain High, Cara Therapeutics Among Top Gainers
Via Benzinga
Topics Cannabis
Cannabis Stock Gainers And Losers From April 11, 2025
Via Benzinga
Topics Cannabis
Cannabis Stock Gainers And Losers From April 8, 2025
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For April 2, 2025
Via Benzinga
Topics Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For April 1, 2025
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For March 28, 2025
Via Benzinga
Topics Cannabis
Marijuana Stock Movers For March 24, 2025
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For March 18, 2025
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For February 17, 2025
Via Benzinga
Topics Cannabis
Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate
Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types. 
Via Benzinga
Bearish Sentiment Across The Cannabis Space - Check Full Movers For January 20, 2025
Via Benzinga
Topics Cannabis
Marijuana Stock Movers For October 23, 2024
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For October 21, 2024
Via Benzinga
Topics Cannabis
Marijuana Stock Movers For October 21, 2024
Via Benzinga
Topics Cannabis
Cannabis Stock Gainers And Losers From October 9, 2024
Via Benzinga
Topics Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For October 8, 2024
Via Benzinga
Topics Cannabis
Cannabis Stock Gainers And Losers From October 4, 2024
Via Benzinga
Topics Cannabis
As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
Viking Therapeutics is an upstart in the weight-loss drugs space. But it's catching attention. 
Via Investor's Business Daily
Cannabis Stock Movers For October 2, 2024
Via Benzinga
Topics Cannabis
Cannabis Stock Gainers And Losers From October 1, 2024
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For September 25, 2024
Via Benzinga
Topics Cannabis
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now
Corbus Pharmaceuticals received buy ratings from H.C. Wainwright and Oppenheimer, citing the company's diversified pipeline. 
Via Benzinga
Cannabis Stock Movers For September 20, 2024
Via Benzinga
Topics Cannabis
Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players
Novo Nordisk announced positive Phase 2a trial results for monlunabant, showing significant weight loss with a 10 mg dose. However, investors reacted to limited gains at higher doses. Corbus... 
Via Benzinga
Crude Oil Moves Higher; Sable Offshore Shares Slide
Via Benzinga
Gold Gains Over 1%; Battalion Oil Shares Spike Higher
Via Benzinga
Corbus Pharma (CRBP) Stock Drops 60% After Novo Nordisk's Cannabinoid-Based Weight Loss Drug Trial Disappoints
Corbus Pharmaceuticals and Novo Nordisk stocks plunge following cannabinoid receptor drug trials, raising concerns over weight loss results. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.